Vitamin B6 (as pyridoxine HCl and pyridoxal-5-phosphate)
50 mg
2,941%
📅 Last updated:
Top Medical Research Studies
8
Vitamin B6 may reduce neuropathy
Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy.
We focused on understanding how vitamin B6 influences chronic chemotherapy-induced peripheral neuropathy (CIPN), a long-lasting side effect experienced by patients undergoing oxaliplatin-based treatment for non-metastatic colorectal cancer. Our study included 242 patients who provided blood samples at multiple points—before starting chemotherapy, during it, and after completing treatment.
We measured several vitamin B6 markers in the blood and examined their connection to the occurrence and severity of chronic CIPN a year post-diagnosis. Our findings revealed that while normal levels of a particular form of vitamin B6 were present, those with higher levels during chemotherapy reported lower instances and reduced severity of CIPN symptoms. This suggests that maintaining adequate vitamin B6 levels may be beneficial for patients facing chemotherapy-related nerve issues.
Still, it’s important to approach these results cautiously. More research is needed to firmly establish a cause-and-effect relationship and to determine the optimal vitamin B6 levels for patients undergoing chemotherapy. This insight could pave the way for better management of neuropathy among cancer patients in the future.
Read More
Most Useful Reviews
10
Neuropathy relief
13 people found this helpful
No more neuropathy. Definitely worth the money; it helps with my neuropathy.
Read More
7.5
Discomfort relief
10 people found this helpful
I’ve been taking this since chemotherapy, as the hospital recommended it to help prevent neuropathy. Although I experienced some discomfort, it has helped relieve it.
Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy.
We focused on understanding how vitamin B6 influences chronic chemotherapy-induced peripheral neuropathy (CIPN), a long-lasting side effect experienced by patients undergoing oxaliplatin-based treatment for non-metastatic colorectal cancer. Our study included 242 patients who provided blood samples at multiple points—before starting chemotherapy, during it, and after completing treatment.
We measured several vitamin B6 markers in the blood and examined their connection to the occurrence and severity of chronic CIPN a year post-diagnosis. Our findings revealed that while normal levels of a particular form of vitamin B6 were present, those with higher levels during chemotherapy reported lower instances and reduced severity of CIPN symptoms. This suggests that maintaining adequate vitamin B6 levels may be beneficial for patients facing chemotherapy-related nerve issues.
Still, it’s important to approach these results cautiously. More research is needed to firmly establish a cause-and-effect relationship and to determine the optimal vitamin B6 levels for patients undergoing chemotherapy. This insight could pave the way for better management of neuropathy among cancer patients in the future.
Read More
User Reviews
USERS' SCORE
Good
Based on 2 Reviews
8.6
All Reviews
Positive Reviews
Negative Reviews
10
Neuropathy relief
13 people found this helpful
No more neuropathy. Definitely worth the money; it helps with my neuropathy.
Read More
7.5
Discomfort relief
10 people found this helpful
I’ve been taking this since chemotherapy, as the hospital recommended it to help prevent neuropathy. Although I experienced some discomfort, it has helped relieve it.
Read More
Frequently Asked Questions
No FAQs are available for this product and symptom.
References
Renting L, Zwart NRK, Ueland PM, McCann A, Ulvik A, et al. Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy. BMJ Oncol. 2024;3:e000462. 10.1136/bmjonc-2024-000462